1don MSN
Ozempic Launched In India: Doctors Welcome New Diabetes Drug, Warn Against Misuse For Weight Loss
Ozempic, the blockbuster weight-loss drug by Novo Nordisk, was launched in India on Friday (December 12). In India, the drug will be marketed for adults with type-2 diabetes, unlike in the US and ...
Scientists have successfully transplanted gene-edited insulin-producing cells into a man with type 1 diabetes—allowing him to ...
Researchers from the Institute of Genetics and Developmental Biology of the Chinese Academy of Sciences (CAS) have uncovered ...
Type 1 diabetes is a disease in which the body mistakenly attacks itself as the immune system destroys the pancreas's insulin ...
From saccharin in the 19th century to stevia and monk fruit in the 21st, researchers and the food industry have long sought a ...
Adding to the growing body of research that proves our microbiome is a powerful ally in fighting disease, scientists have ...
5don MSN
Microbial molecule that disarms inflammation discovered, offering new diabetes treatment strategy
An international research team has uncovered a surprising ally in the fight against insulin resistance and type 2 diabetes: a ...
Researchers revealed that the microbial metabolite TMA can directly block the immune protein IRAK4, reducing inflammation and ...
News-Medical.Net on MSN
Single-cell RNA-seq reveals FBLN7's role in adipose tissue fibrosis
Fibrosis, resulting from excess extracellular matrix (ECM) deposition, is a feature of adipose tissue (AT) dysfunction and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results